Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Dec 04, 2020 1:43pm
129 Views
Post# 32038335

RE:RE:RE:RE:RE:It may have bottomed.

RE:RE:RE:RE:RE:It may have bottomed.This is for the recent private placement of 14,210,522 shares and the fee was $6,278.99, don't know about $100K in legal fees, sounds absurd.

Private Placement of Common Shares, Prefunded Warrants and Warrants

On October 29, 2020, we, Structured Alpha LP, or SALP, and Armistice Capital Master Fund Ltd., or Armistice, entered into a Securities Purchase Agreement, as amended in November 2020, or the Purchase Agreement, and a Registration Rights Agreement, or the RRA, as part of a private placement, which we refer to as the Private Placement. Pursuant to the Purchase Agreement, the selling shareholders purchased in a private placement an aggregate of (i) 5,757,894 common shares, (ii) prefunded warrants to purchase up to 557,894 common shares at an exercise price of $0.001 per share, which we refer to as the Prefunded Warrants, and (iii) warrants to purchase up to 7,894,734 common shares at an exercise price of $5.50 per share, which we refer to as the Warrants. 

GunnerG wrote: We already went through this process for all of SALP and Con shares.  I remember pumpers saying the same thing as is posted here and I responded that we got the privilege of payinge the expenses.

Here we are again paying fees and another $100,000 for legal fees.  Bend over SH.

Does anyone know if we actually have employess in QC or is just executives and BOD?

Also, what is the dilution of a $200M financing of a company with a current market cap of $122M?


aldo451 wrote: Hey Solmig, I'm no expert but I don’t think this says that they are selling shares, this would make no sense as they just purchased them for $5.50. I believe what it says is that they are registering the shares so that they can trade them. Is this good or bad? Could be seen as a good thing as it may be a signal that they want to part of the upswing or perhaps even use the shares to generate the upswing...

After all, Thomvest's average cost is close to $14/share!




<< Previous
Bullboard Posts
Next >>